Intellipharmaceutics International, a specialty pharmaceutical company, has appointed Graham Neil, chartered accountant (CA), as chief financial officer (CFO) and vice president, finance.
Neil has over 10 years of public company and healthcare industry experience. Most recently, he served as CFO for a Nasdaq- and TSX-listed development-stage company. Prior to his public company experience, Neil served with KPMG.
A report by broking group Marsh examines the repercussions from the administration of the South Korean company, which filed for bankruptcy protection at the end of August.
Global research by C2FO suggests that smaller businesses are less concerned with the repercussions of Brexit and the upcoming US presidential election.
A squeeze on skilled talent means it now takes an average of seven weeks to fill open permanent roles in finance in the UK according to new research from financial services recruitment firm Robert Half.
Early-stage merger and acquisition deals in Asia-Pacific show nearly 10% year-on-year growth in recent months.